These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 17765871)

  • 1. Identification of GPR55 as a lysophosphatidylinositol receptor.
    Oka S; Nakajima K; Yamashita A; Kishimoto S; Sugiura T
    Biochem Biophys Res Commun; 2007 Nov; 362(4):928-34. PubMed ID: 17765871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
    Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
    J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.
    Oka S; Toshida T; Maruyama K; Nakajima K; Yamashita A; Sugiura T
    J Biochem; 2009 Jan; 145(1):13-20. PubMed ID: 18845565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.
    Zhao P; Abood ME
    Life Sci; 2013 Mar; 92(8-9):453-7. PubMed ID: 22820167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
    Nevalainen T; Irving AJ
    Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms.
    Tobo M; Tomura H; Mogi C; Wang JQ; Liu JP; Komachi M; Damirin A; Kimura T; Murata N; Kurose H; Sato K; Okajima F
    Cell Signal; 2007 Aug; 19(8):1745-53. PubMed ID: 17462861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential changes in GPR55 during microglial cell activation.
    Pietr M; Kozela E; Levy R; Rimmerman N; Lin YH; Stella N; Vogel Z; Juknat A
    FEBS Lett; 2009 Jun; 583(12):2071-6. PubMed ID: 19464294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
    Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
    FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
    Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enigmatic pharmacology of GPR55.
    Ross RA
    Trends Pharmacol Sci; 2009 Mar; 30(3):156-63. PubMed ID: 19233486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.
    Brown AJ; Daniels DA; Kassim M; Brown S; Haslam CP; Terrell VR; Brown J; Nichols PL; Staton PC; Wise A; Dowell SJ
    J Pharmacol Exp Ther; 2011 Apr; 337(1):236-46. PubMed ID: 21233197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
    Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
    J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the natural ligand of GPR55?
    Okuno T; Yokomizo T
    J Biochem; 2011 May; 149(5):495-7. PubMed ID: 21324983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
    Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
    J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico patent searching reveals a new cannabinoid receptor.
    Baker D; Pryce G; Davies WL; Hiley CR
    Trends Pharmacol Sci; 2006 Jan; 27(1):1-4. PubMed ID: 16318877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.
    Piñeiro R; Maffucci T; Falasca M
    Oncogene; 2011 Jan; 30(2):142-52. PubMed ID: 20838378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors.
    Anavi-Goffer S; Irving AJ; Ross RA
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylinositol Induced Morphological Changes and Stress Fiber Formation through the GPR55-RhoA-ROCK Pathway.
    Nakajima K; Oka S; Tanikawa T; Nemoto-Sasaki Y; Matsumoto N; Ishiguro H; Arata Y; Sugiura T; Yamashita A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR55 as a new cannabinoid receptor: still a long way to prove it.
    Petitet F; Donlan M; Michel A
    Chem Biol Drug Des; 2006 Mar; 67(3):252-3. PubMed ID: 16611220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.